-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Immunocore Holdings, Raises Price Target to $86

Benzinga·05/08/2025 14:28:17
Listen to the news
Oppenheimer analyst Jeff Jones maintains Immunocore Holdings (NASDAQ:IMCR) with a Outperform and raises the price target from $85 to $86.